QIMR Berghofer Medical Research Institute

QIMR Berghofer Medical Research Institute is an Australian medical research organisation that conducts scientific investigations to understand the causes, prevention and treatment of human disease. As a research institute, it brings together scientists, clinicians and technical staff to study a broad spectrum of health conditions. Its work aims to generate new knowledge that can be translated into improved diagnostics, therapies and public health strategies. The institute collaborates with hospitals, universities and other research entities both nationally and internationally. Through these partnerships it seeks to accelerate the application of discoveries into clinical practice. Its activities are supported by competitive grant funding and philanthropic contributions.

Headquartered in Australia, QIMR Berghofer operates as a not-for-profit medical research institute dedicated to advancing health outcomes through evidence‑based science. The organisation places a strong emphasis on translating laboratory findings into real‑world health benefits, a distinguishing attribute of its mission. In December 2020 the institute experienced a data breach involving a zero‑day vulnerability in Accellion’s legacy FTA file transfer service, which resulted in unauthorized access to anonymised clinical trial data and some employee résumés. This incident highlighted the importance of robust cybersecurity protections for research institutions handling sensitive information. While the breach did not expose personally identifiable information, it prompted a review of data security practices across the organisation. The institute continues to pursue its research agenda while maintaining commitments to privacy and data protection.